<i>MET</i> amplification as a potential therapeutic target in gastric cancer
Hisato Kawakami(Tohoku University), Yasuhide Yamada(National Center for Global Health and Medicine)
Cited by 86
Related Papers
Trastuzumab deruxtecan (DS-8201) in patients with HER2-expressing metastatic colorectal cancer (DESTINY-CRC01): a multicentre, open-label, phase 2 trial
|The Lancet Oncology|2021|411
Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies
|Nature Medicine|2020|366
FGFR2 gene amplification and clinicopathological features in gastric cancer
|British Journal of Cancer|2012|182
Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancer
|Investigational New Drugs|2017|170